MECHELEN, BELGIUM--(Marketwire - Jan 6, 2013) - Galapagos NV (EURONEXT BRUSSELS: GLPG)
announced
today that Onno van de Stolpe, CEO of Galapagos, will present at the
31(st)
annual J. P. Morgan Healthcare Conference on Thursday, January 10(th) at
9:00
a.m. (PST) / 12 p.m. (EST)/ 18.00 (CET) in San Francisco. The
presentation
will be held in the Elizabethan A/B room in the Westin St. Francis and will
also
be webcast.
Click here to access the webcast or go to www.glpg.com to access a PDF
of the
presentation slides. A replay of the presentation will be available
for 90
days.
About Galapagos
Galapagos (EURONEXT BRUSSELS: GLPG) (PINKSHEETS: GLPYY) is a mid-size
clinical stage
biotechnology company specialized in the discovery and development of
small
molecule and antibody therapies with novel modes-of-action. The
Company is
progressing its JAK1 inhibitor GLPG0634, as well as one of the largest
pipelines
in biotech, with four programs in development and over 30 discovery
programs.
The Galapagos Group has over 800 employees and operates facilities in
five
countries, with global headquarters in Mechelen, Belgium. More
info at:
www.glpg.com
This release may contain forward-looking statements, including,
without
limitation, statements containing the words "believes,"
"anticipates,"
"expects," "intends," "plans," "seeks," "estimates," "may," "will,"
"could,"
"stands to," and "continues," as well as similar expressions. Such
forward-
looking statements may involve known and unknown risks, uncertainties and
other
factors which might cause the actual results, financial condition,
performance
or achievements of Galapagos, or industry results, to be materially
different
from any historic or future results, financial conditions,
performance or
achievements expressed or implied by such forward-looking statements.
Given
these uncertainties, the reader is advised not to place any undue
reliance on
such forward-looking statements. These forward-looking statements speak
only as
of the date of publication of this document. Galapagos expressly
disclaims any
obligation to update any such forward-looking statements in this
document to
reflect any change in its expectations with regard thereto or any
change in
events, conditions or circumstances on which any such statement is based,
unless
required by law or regulation.
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Galapagos NV via Thomson Reuters ONE
[HUG#1668408]
CONTACT
Galapagos NV
Elizabeth Goodwin
Director Investor Relations
Tel: +31 6 2291 6240Email Contact
View More
View More
